How should a 4-year-old with a TSH of 2,336 µU/L and free T4 of 16 pmol/L be treated?

Immediate Levothyroxine Treatment Required

A 4-year-old with TSH of 2,336 µU/L must start levothyroxine immediately, regardless of the free T4 level of 16 pmol/L, as this represents severe primary hypothyroidism requiring urgent treatment to prevent neurocognitive impairment.

Treatment Initiation

Given the extraordinarily elevated TSH (>2,000 µU/L), treatment should begin without delay. The European Society for Paediatric Endocrinology guidelines clearly state that if venous TSH concentration is ≥ 20 mU/L, treatment should be started, even if FT4 concentration is normal 1. Your patient's TSH far exceeds this threshold.

Initial Levothyroxine Dosing

For a 4-year-old with acquired hypothyroidism (not congenital), the appropriate starting dose differs significantly from neonatal dosing:

• Start with 1.5-2.0 µg/kg/day of levothyroxine 2
• Children aged 6-10 years typically require approximately 2.0 µg/kg/day
• This is substantially lower than the 10-15 µg/kg/day used for congenital hypothyroidism 1

The free T4 of 16 pmol/L (assuming normal range ~12-22 pmol/L) suggests some residual thyroid function, making this acquired rather than congenital hypothyroidism, which influences dosing strategy.

Administration Guidelines

• Use brand-name levothyroxine tablets (not generic), crushed if needed and mixed with small amounts of water 1
• Administer consistently at the same time daily (morning or evening)
• Avoid concurrent intake with soy, iron, calcium, or vitamin D during the first weeks 1
• Provide written instructions to parents 1

Urgent Diagnostic Workup

Do not delay treatment to obtain imaging, but arrange the following concurrently 1:

Required Investigations

1. Thyroid imaging: Ultrasound or radioisotope scan to determine etiology (thyroid dysgenesis vs. dyshormonogenesis vs. autoimmune thyroiditis)
2. Anti-thyroid antibodies: Anti-TPO and anti-thyroglobulin to identify autoimmune thyroiditis (most common cause in this age group) 3
3. Physical examination: Assess for goiter, cardiac abnormalities, and dysmorphic features 1
4. Growth parameters: Height, weight, and bone age assessment

Critical Pitfall to Avoid

With such markedly elevated TSH, consider thyroid hormone resistance (RTHβ) in the differential diagnosis, though less likely given the clinical context. RTHβ presents with elevated TSH alongside elevated free T4 and T3, not low-normal T4 4. However, if TSH fails to normalize despite adequate dosing, genetic testing for THRB mutations should be considered.

Monitoring Protocol

Initial Phase (First 2-4 Weeks)

• First follow-up at 1-2 weeks after starting treatment 1
• Check TSH and free T4 at least 4 hours after last levothyroxine dose 1
• Expect TSH to decrease by 50% within 3-4 days, but complete normalization takes 4-6 weeks 5
• Free T4 should normalize within days, but do not reduce dose based solely on elevated free T4 during initial treatment 1

Ongoing Monitoring for Ages 1-3 Years

• Every 2-4 months for clinical and laboratory evaluation 1
• Target TSH in age-specific reference range (avoid undetectable levels <0.05 mU/L)
• Target free T4 in upper half of age-specific reference range 1
• More frequent monitoring if compliance questioned or abnormal values obtained

Treatment Goals and Prognosis

The severity of this presentation (TSH >2,000 µU/L) indicates significant thyroid dysfunction. Rapid normalization of thyroid hormones is crucial to minimize impact on growth, development, and neurocognitive function 1.

Expected Outcomes

• Growth velocity should improve within months of adequate treatment
• Symptoms (if present: constipation, lethargy, dry skin, poor growth) should resolve
• Monitor for ADHD or learning difficulties, which occur in some children with severe hypothyroidism 1, 4

Long-term Considerations

If autoimmune thyroiditis is confirmed, this will likely require lifelong levothyroxine therapy. Re-evaluation of thyroid function off medication is not indicated for autoimmune hypothyroidism, unlike transient forms 1. Regular monitoring every 3-12 months will be needed until growth completion 1.

Key Point: The combination of extremely elevated TSH with relatively preserved free T4 suggests progressive thyroid failure, making prompt treatment initiation essential to prevent further deterioration and optimize developmental outcomes.